Rowan and Sentrimed University®IN The Biofarmaceutical Company on the clinical stage focused on the development of safer, orally administered oncology therapy, today announced the results from Nation financed by® In patients with oral squamous cell carcinoma (OSCC). The main candidate for the company’s product, Masl, is innovative therapeutic Lekine Licensed at the University of Rowan. […]
Tag Archives: targeted
Scientists from POSTECH and Kyungpook National University have developed a novel inhalation drug delivery system for lung cancer using mucoadhesive protein nanoparticles inspired by the adhesive properties of marine mussels. This work was initiated by Professor Hyung Joon Cha (Department of Chemical Engineering and Graduate School of Convergence Science and Technology with specialization in Medical […]